Skip to main content
Signal8

LYNCH DANIEL

SEC insider (Form 3/4/5 filer). CIK 0001177082. Director at SpringWorks Therapeutics, Inc. (SWTX). 8 reported Form 4/5 transactions since Sep 2024; latest on Jul 1, 2025. Located in STAMFORD, CT.

Companies LYNCH DANIEL has filed insider reports for

  • SpringWorks Therapeutics, Inc. (SWTX): Director
LYNCH DANIEL profile photo

LYNCH DANIEL

CIK: 0001177082

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)6 (75.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (12.5%)

Compensation grants

Other (G, F, J, C, D, …)1 (12.5%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SpringWorks Therapeutics, Inc. logo
SWTX

SpringWorks Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (8 total)

  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Jul 1, 2025
    Disposition
    Direct
    93K shares-
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    May 14, 2025
    Award
    Direct
    10.1K shares-
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Feb 20, 2025
    Sale
    Direct
    44K shares at avg. $60.14$2.6M
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Feb 20, 2025
    Sale
    Direct
    3.6K shares at avg. $61.24$219K
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Feb 14, 2025
    Sale
    Direct
    400 shares at avg. $60.00$24K
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Feb 10, 2025
    Sale
    Direct
    65.6K shares at avg. $55.51$3.6M
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Feb 10, 2025
    Sale
    Direct
    39.6K shares at avg. $54.88$2.2M
  • SpringWorks Therapeutics, Inc. logo
    SWTX

    SpringWorks Therapeutics, Inc.

    Feb 10, 2025
    Sale
    Direct
    69.8K shares at avg. $53.23$3.7M

1-8 of 8